Improved posthypoxic recovery in vitro on treatment with drugs used for secondary stroke prevention

被引:12
作者
Huber, R [1 ]
Riepe, MW [1 ]
机构
[1] Univ Ulm, Dept Neurol, D-89075 Ulm, Germany
关键词
neuroprotection; hypoxia; platelet inhibition; HMG-CoA reductase inhibition;
D O I
10.1016/j.neuropharm.2004.12.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Besides aspirin several new drugs for inhibition of platelet aggregation and 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) reductase inhibition are used in secondary stroke prevention. Pharmacology and clinical effects, however, are not fully explained by current understanding of underlying mechanisms. Population spike amplitude (PSAP), an established marker of slice integrity, was measured during hypoxia and recovery thereof in hippocampal slices from control CD1 mice (25-35 g) and animals pretreated in vivo with a single i.p. injection of clopidogrel, ticlopidine, or atorvastatine at different time intervals and dosages. Posthypoxic recovery of PSAP was 20 +/- 35% in control CD1 mice. Upon pretreatment with clopidogrel (1-24 h, 0.5-2 mg/kg body weight) an increase up to 81 +/- 20% (p < 0.01 to control) was observed at I h interval and I mg/kg. Application of ticlopidine (1-24 h, 1-4 mg/kg body weight) resulted in an improvement of posthypoxic recovery to 61 +/- 41 % (p < 0.05 to control) while administration of atorvastatine (1-24 h, 1-4 mg/kg body weight) caused an increase up to 87 +/- 31 % (p < 0.01 to control) at I h interval and 2 mg/kg. On application of these substances in vitro the NADH autolluorescence spectrum in hippocampal slices is blue-shifted suggesting an alteration of oxidative metabolism. The present data demonstrate a shared neuroprotective effect of agents known to inhibit platelets (acetylsalicylic acid, clopidogrel, and ticlopidine) and HMG-CoA reductase (atorvastatine). The time course of this neuroprotective action in the current experimental study (onset within an hour, duration of several hours in contrast to several days) resembles clinical practice in dosing these substances. We hypothesize that an increase of hypoxic tolerance resulting from mild mitochondrial inhibition by these substances is a principal constituent of the effectiveness of these drugs. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:558 / 565
页数:8
相关论文
共 40 条
  • [1] MECHANISM OF INTERACTION OF TICLOPIDINE AND ITS ANALOGS WITH THE ENERGY-CONSERVING MECHANISM IN MITOCHONDRIA
    ABOUKHALIL, S
    ABOUKHALIL, WH
    YUNIS, AA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (11) : 1855 - 1859
  • [2] EFFECTS OF TICLOPIDINE, A NEW PLATELET ANTIAGGREGATING AGENT, AND ITS ANALOGS ON MITOCHONDRIAL METABOLISM - OXIDATIVE-PHOSPHORYLATION, PROTEIN-SYNTHESIS AND DNA-POLYMERASE ACTIVITY
    ABOUKHALIL, WH
    LIM, LO
    YUNIS, AA
    ABOUKHALIL, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 1984, 33 (23) : 3893 - 3898
  • [3] CLOSE CORRELATION BETWEEN PLATELET RESPONSES AND ADENYLATE ENERGY-CHARGE DURING TRANSIENT SUBSTRATE DEPLETION
    AKKERMAN, JWN
    GORTER, G
    SOONS, H
    HOLMSEN, H
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 760 (01) : 34 - 41
  • [4] Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice
    Amin-Hanjani, S
    Stagliano, NE
    Yamada, M
    Huang, PL
    Liao, JK
    Moskowitz, MA
    [J]. STROKE, 2001, 32 (04) : 980 - 985
  • [5] Trans-synaptic increase of hypoxic tolerance in hippocampus upon physical challenge with two-photon microscopy
    Büchner, M
    Huber, R
    Riepe, MW
    [J]. HIPPOCAMPUS, 2002, 12 (06) : 765 - 773
  • [6] Lipid-lowering drugs and mitochondrial function: Effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio
    DePinieux, G
    Chariot, P
    AmmiSaid, M
    Louarn, F
    Lejonc, JL
    Astier, A
    Jacotot, B
    Gherardi, R
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (03) : 333 - 337
  • [7] Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation
    Dörr, G
    Schmidt, G
    Gräfe, M
    Regitz-Zagrosek, V
    Fleck, E
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 39 (04) : 523 - 532
  • [8] Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
    Endres, M
    Laufs, U
    Huang, ZH
    Nakamura, T
    Huang, P
    Moskowitz, MA
    Liao, JK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8880 - 8885
  • [9] 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells -: Role of geranylgeranylation and Rho proteins
    Essig, M
    Nguyen, G
    Prié, D
    Escoubet, B
    Sraer, JD
    Friedlander, G
    [J]. CIRCULATION RESEARCH, 1998, 83 (07) : 683 - 690
  • [10] N-METHYL-D-ASPARTATE RECEPTOR ACTIVATION AND CA-2+ ACCOUNT FOR POOR PYRAMIDAL CELL STRUCTURE IN HIPPOCAMPAL SLICES
    FEIG, S
    LIPTON, P
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 55 (02) : 473 - 483